Wealth Enhancement Advisory Services, LLC Ptc Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 10,753 shares of PTCT stock, worth $514,638. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,753
Previous 11,670
7.86%
Holding current value
$514,638
Previous $594,000
11.62%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
287Shares Held
78.8MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$412 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$372 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$358 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$260 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$259 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.42B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...